Story by Kettering Adventist HealthCare Staff
The COVID-19 monoclonal antibody treatment, Bamlanivimab, is being used for qualified patients at Kettering Adventist HealthCare.
The Food and Drug Administration gave emergency use authorization of the monoclonal antibody Bamlanivimab. Patients may be eligible for the infusion treatment if they are suffering from moderate symptoms of COVID-19 including, but not limited to
• Shortness of breath